Eubiotics Market Size, Share, Growth, and Industry Analysis, By Type (Probiotics,Organic Acid), By Application (Animals,Application 2), Regional Insights and Forecast to 2035

Eubiotics Market Overview

The global Eubiotics Market is forecast to expand from USD 5249.97 million in 2026 to USD 5533.47 million in 2027, and is expected to reach USD 8427.96 million by 2035, growing at a CAGR of 5.4% over the forecast period.

The global Eubiotics Market Market was estimated at USD 4.6 billion in 2021 and grew to approximately USD 4.9 billion in 2022. Europe held a share in excess of 43 % of the total global market in 2021. The largest segment by type was probiotics, accounting for roughly 41.7 % of market share in 2024. In the livestock category, the poultry segment captured about 34.5 % of the market in 2024.

The global eubiotics market size reached USD 4.9 billion in 2024 and is forecast to reach USD 8.9 billion by 2033. 🇺🇸 In the USA market, the United States eubiotics market size was estimated at USD 1,349.4 million in 2024, with solid (tablet/flake) forms dominating the product mix and probiotics segment holding the largest share.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 36% of the market growth is driven by the rising prevalence of cancer and demand for precision oncology.
• Major Market Restraint: 22% of market limitations arise from the high cost and limited reimbursement of genomic testing.
• Emerging Trends: 29% of market developments stem from AI-based genomic analytics and liquid biopsy innovations.
• Regional Leadership: 38% of total market share is concentrated in North America due to research dominance and regulatory support.
• Competitive Landscape: 24% of industry activity involves mergers and collaborations between biotech and diagnostic firms.
• Market Segmentation: 31% of the market is led by sequencing technologies, followed by PCR and microarray platforms.
• Recent Development: 18% of innovation in 2024 was attributed to cloud-based genomic data management and cancer genomics AI tools.

Eubiotics Market Latest Trends

In the Eubiotics Market Market Research Report, a major trend is the rising uptake of probiotics in the livestock feed segment. In 2024 the probiotics type accounted for approximately 41.7 % of the global market share; this segment remains dominant as end-users pursue improved gut health and performance outcomes in poultry and swine. The feed-efficiency/immunity function segment contributed about 55 % of market value in 2024. Secondly, liquid forms, although smaller than solid, continue expanding due to demand for enhanced delivery in aquaculture and ruminant systems.

In the USA, the market size stood at USD 1,349.4 million in 2024. Emerging product innovation, such as spore-forming and encapsulated eubiotics, are gaining traction driven by concerns about raw-material stability and moisture/heat sensitivity of essential oils. In the Eubiotics Market Industry Analysis, feed-additive consumers increasingly prefer natural, antibiotic-free solutions; this is evident in the fact that more than 60 % of livestock producers in certain regions adopted eubiotics solutions by 2023. The competition is intensifying as manufacturers focus on vertical integration and feed-mill acquisitions in North America.

Eubiotics Market Dynamics

DRIVER:

"Rising awareness of gut-health and antibiotic-free animal production"

In the Eubiotics Market Market Research Report, rising awareness of gut-health and antibiotic-free production is cited as a key driver: the global market reached USD 4.9 billion in 2024, and the function segment of gut-health and performance accounted for 55 % of the market value in 2024. Regulatory restrictions on antibiotic growth promoters have been enforced in multiple countries, prompting a shift to eubiotics. 

RESTRAINTS

"Supply-chain and raw material instability"

Despite favourable demand in the Eubiotics Market Market Studies, supply-chain challenges pose restraints: essential oils and phytogenic raw materials used in eubiotics are plant-derived and subject to quality-control, moisture and heat instability. For example, unavailability of raw materials was highlighted as a significant concern in the USA market insight report, slowing product launches and scale-up. 

OPPORTUNITY

"Expansion of aquaculture and specialty livestock feed segments"

The Eubiotics Market Market Opportunities are significant: the aquaculture segment is emerging rapidly — in a recent industry report the poultry segment held 34.5 % share in 2024, while aquaculture is projected as a fast-growing livestock category in the eubiotics market size discussion. The growth in aquaculture, along with rising dairy production and specialty ruminant feed demand, opens new applications for eubiotics beyond mainstream poultry and swine. 

CHALLENGE

"High cost of validated research and regulatory harmonisation"

One of the key challenges in the Eubiotics Market Market Research is the high cost of clinical validation, R&D for spore-forming and encapsulation technologies, and the complexity of regulatory harmonisation across global markets. Many feed-additive producers face dual regulations relating to animal feed and veterinary health claims, slowing product registration. 

Eubiotics Market Segmentation

The Eubiotics Market Market segmentation covers type, application, form and region with precise numerical weightings: by type, probiotics held ~41.7% share in 2024 and organic acids composed a material portion of the mix (~USD 1.2–1.9 billion range in 2024 across feed uses). By application, gut-health/performance applications represented roughly 55% of value in 2024 while poultry accounted for ~34.5% of livestock demand; solids (dry) formats comprised about 61% of product form usage. Regional splits show Europe >43% share (2021 baseline) with North America and Asia-Pacific following.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Probiotics: Probiotics dominated the type mix in the Eubiotics Market Market, accounting for ~41.7% of total type share in 2024 and representing the largest single technology bucket among all eubiotics offerings; probiotics also lead in feed and additive unit volumes globally. In absolute terms the probiotics portion within eubiotics translates into hundreds of millions of USD-equivalent sales and the broader probiotics industry recorded multi-billion dollar market flows in 2023–2024. 

Probiotics Market Size, Share and CAGR for Probiotics: The probiotics type within eubiotics represented ~41.7% share in 2024 with an implied market size in the hundreds of millions and an industry CAGR estimate in the single-digit to low-teens range over 2024–2030. 

Top 5 Major Dominant Countries in the Probiotics Segment

• United States — Estimated probiotics demand in the US exceeded USD 10–15 billion in adjacent probiotics markets in 2023–2024, representing a dominant share and a mid-single digit to high-single digit growth trajectory. 
• China — China probiotic revenues were ~USD 6,382 million in 2023, ranking China among top markets with strong double-digit expansion expectations in several reports. 
• Germany — Germany as Europe’s industrial centre captured a top-country share within European probiotic/eubiotics demand, contributing high-single digit percentage shares to the regional 43%+ figure. 
• Brazil — Brazil is one of Latin America’s largest probiotic consumers with multi-hundred million USD market volumes and rising penetration in animal feed and human probiotics segments.
• India — India shows growing probiotic adoption with market volumes in the low-to-mid hundreds of millions USD in 2023–2024 and elevated growth rates driven by food, feed and supplements uptake. 

Organic Acid: Organic acids (feed acidifiers and blends) are a major eubiotics sub-type; multiple market estimates place the animal-nutrition organic-acid pool in the ~USD 1.2–1.9 billion band in 2024 specifically for animal feed uses, while broader organic-acid markets (all uses) exceeded USD 12–28 billion in 2024 depending on scope. 

Organic Acid Market Size, Share and CAGR for Organic Acid: The organic-acid type within eubiotics equates to ~USD 1.2–1.9 billion in feed-centric market size in 2024, with reported sector CAGRs typically mid-single digits across 2024–2034 in animal-nutrition studies.

BY APPLICATION

Animals : Ruminant use focuses on rumen modifiers and targeted probiotics for milk yield and feed efficiency. Industry estimates place eubiotics total demand (animal application) at the majority of the global eubiotics value—several billion USD—driven by regulatory bans on antibiotic growth promoters, stronger food-safety requirements from exporters and integrated feed-mill adoption of premix blends. 

The global Eubiotics Market Market shows concentrated demand in Europe (>43% share in 2021) and robust North American adoption; Asia-Pacific and Latin America present sizable volume upside while MEA remains nascent under 10% share. Feed-form preference skews toward dry/solid formats (approx. 60–68% share in recent reports) with liquid formats growing fastest in aquaculture applications. Poultry is the single largest livestock application (~34.5% share in 2024) while gut-health/performance functions account for an estimated ~55% of total application value.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America 

North America represents a significant portion of global eubiotics demand with the United States leading adoption; dry formulations dominate (~60–65% share) and poultry/swine drive consumption. Market concentration is moderate: top five suppliers controlled roughly 40–45% of regional value in recent studies, while feed-mill consolidation and antibiotic-use restrictions support substitution to eubiotics. The region shows strong product innovation in encapsulation and strain development with notable liquid-format growth for aquaculture. North American producers report that more than 50% of mid- to large-scale feed operators have trialled eubiotics solutions by 2023. 

The North America eubiotics market was estimated at roughly USD 1.74 billion in 2024, representing a high single-digit percentage share of global value and mid-to-high single-digit CAGR outlook through the next decade. 

North America - Major Dominant Countries in the “Eubiotics Market”

• United States — The US eubiotics market (approx. USD 1.35 billion in 2024) holds the largest North American share with advanced feed-mill adoption and a projected mid-single digit CAGR. 
• Canada — Canada accounts for a mid-single digit percentage of North American eubiotics demand, driven by poultry and ruminant segments and steady double-digit trial rates among feed formulators. 
• Mexico — Mexico represents low-to-mid single-digit North American share with expanding aquaculture and poultry usage and rising imports of formulated eubiotics premixes. 
• Puerto Rico (as a US territory) — Puerto Rico contributes a fractional share in North America with niche aquaculture and specialty feed trials, showing accelerated product adoption in certain commercial farms. 
• Other North America (Caribbean suppliers/import hubs) — Smaller markets combined represent a modest share with growing reliance on imported probiotic and organic-acid premixes and pilot program adoption rates above 20%. 

Europe 

Europe has been the dominant region historically, with reported share exceeding 43% in 2021 and continued leadership in eubiotics innovation, regulatory alignment and premium feed adoption. Dry formulations and probiotics are especially prevalent; poultry, pork and ruminant sectors collectively account for the majority of demand. Europe’s feed-mill integration and stringent antibiotic-use policies accelerate substitution to eubiotics. The region also hosts many of the top suppliers and research collaborations, with over 60% of European commercial feed operators engaging in eubiotics trials by 2023. Europe maintains a high concentration of value creation in Western EU member states.

Europe’s eubiotics market accounted for over 40% of global share in early 2020s, with a 2024 regional market size in the low-to-mid billions and a sustained mid-single digit growth trajectory through the forecast period. 

Europe - Major Dominant Countries in the “Eubiotics Market”

• Germany — Germany ranks among top European countries with a high single-digit share of regional eubiotics consumption, driven by intensive livestock production and industrial feed formulation adoption. 
• France — France contributes a strong share within Europe’s >40% regional market, powered by poultry and pork sectors and substantive industrial premix demand. 
• Spain — Spain is a major adopter in Southern Europe with substantial poultry and pig farm integration, accounting for a notable multi-percentage share of Europe’s eubiotics volume. 
• Italy — Italy is a leading country for processed-meat supply chains and premium feed adoption, representing a meaningful portion of Europe’s eubiotics market. 
• Netherlands — The Netherlands contributes a significant share via intensive poultry and dairy chains and high per-tonne eubiotics spending, reflecting advanced feed technology uptake. 

Asia-Pacific 

Asia-Pacific presents strong volume demand and fastest adoption potential, with China and Southeast Asia leading aquaculture and poultry uptake; regional share estimates vary but Asia-Pacific is a major and growing portion of global unit volumes. Liquid formats and species-specific probiotics are expanding due to aquaculture demand, and dry formats remain predominant in large feed mills. Several reports indicate Asia-Pacific market size in the low billions by mid-2020s and rapid scale-up of production capacity and local formulation capabilities across China, Vietnam, India and Indonesia. 

Asia-Pacific eubiotics demand reached multi-billion dollar scale by the mid-2020s, representing a substantial and increasing share of global volumes with a mid-to-high single-digit compound growth outlook driven by China and Southeast Asia. 

Asia - Major Dominant Countries in the “Eubiotics Market”

• China — China leads Asia-Pacific with the largest eubiotics volume driven by poultry, swine and aquaculture, accounting for the region’s single largest country share and high adoption in 2023–2024. 
• India — India holds growing market share with increasing poultry and dairy feed adoption and accelerating domestic probiotic production capacity from a lower base. 
• Vietnam — Vietnam is prominent in aquaculture eubiotics demand, especially shrimp feed, representing a critical Southeast Asian country share with robust per-farm adoption. 
• Indonesia — Indonesia’s large aquaculture and poultry sectors deliver sizable eubiotics volumes, reflecting high regional per-capita consumption of aquaculture feed additives. 
• Thailand — Thailand contributes meaningful regional share through shrimp and fish feed markets with dedicated probiotic formulations and increasing commercial trial adoption. 

Middle East & Africa 

Middle East & Africa (MEA) currently represent a smaller portion of global eubiotics value (often below 10% combined), but show heterogenous adoption: North Africa and Gulf states adopt higher-value, export-driven feed solutions while sub-Saharan markets rely more on indigenous phytogenic blends. MEA markets emphasize heat-stable formulations and local botanicals; microbial eubiotics still account for the majority in several African markets. Recent regional reports show gradual market expansion with pilot programs, university research collaborations and rising export demand from producers seeking antibiotic-free credentials for international buyers. 

The Middle East & Africa eubiotics market represented a modest share in the mid-2020s (under 10% globally), with MEA regional market size measured in the low-to-mid tens of millions and steady growth momentum. 

Middle East and Africa - Major Dominant Countries in the “Eubiotics Market”

• South Africa — South Africa leads African eubiotics uptake with the largest regional share, notable microbial probiotic usage and growing interest in plant-derived eubiotics for export-oriented producers. 
• Egypt — Egypt is among North Africa’s largest feed markets, with increasing adoption of eubiotics in poultry and aquaculture to meet export standards and domestic demand. 
• United Arab Emirates — UAE acts as a regional import and distribution hub with niche adoption of premium eubiotics for high-value livestock and aquaculture farms. 
• Saudi Arabia — Saudi Arabia shows growing feed additive investment and pilot programs for probiotics and organic-acid blends in commercial poultry and dairy operations. 
• Kenya — Kenya is an emerging East African market with increasing use of eubiotics in poultry value chains and smallholder integration through cooperative purchasing programs. 

List of Top Eubiotics Market Companies

• Royal DSM
• BASF SE
• DowDuPont
• Cargill Incorporated
• Kemin Industries
• SCC Holdings Berhad
• Behn Meyer Group
• Chr. Hansen A/S
• YARA International Asa
• Beneo Group

Top two companies with highes

Royal DSM :  ~30% share in supply to poultry and swine premix channels, presence in 50+ countries and supplying to over 30% of commercial poultry operations in leading markets .

BASF SE : ~28% regional share across Europe and North America in formulated eubiotics and feed-additive blends, active in 40+ countries and serving large feed-mill networks .

Investment Analysis and Opportunities

The global eubiotics market recorded multi-billion scale values in the mid-2020s (reported estimates between USD 4.6–6.3 billion for 2021–2024), with probiotics accounting for ~41.7% of type share and poultry representing ~34.5% of livestock demand — clear signals for investor focus on core product lines. Europe held >43% regional share in earlier baselines and North America/Asia-Pacific represent large volume pools; feed-mill consolidation sees top suppliers controlling 40–45% of regional value in some markets, indicating M&A opportunity.

Aquaculture and specialty ruminant applications already show double-digit uptake in select countries, and liquid/encapsulated delivery formats now represent a growing portion of new product pipelines (fact figures: probiotics 41.7%, poultry 34.5%, Europe >43%). Private equity and strategic acquirers are targeting captive premix capabilities and formulation IP: over 50% of mid-to-large scale feed operators trialled eubiotics by 2023, signalling de-risked commercialisation pathways. Public-market investors can prioritise firms with demonstrated supply-chain control (top-3 supplier concentration ~40%) .

New Product Development

Innovation activity centers on stabilized probiotics, spore-forming strains, encapsulation for heat/moisture resistance, and multi-functional blends (probiotic + prebiotic + organic acid). Reports show probiotics leading type share at ~41.7% and dry/solid formats still dominate (~60–68% share) but liquid formats are expanding especially in aquaculture where targeted delivery matters. Manufacturers have increased R&D spend to validate strain efficacy: fewer than 25% of commercial eubiotic SKUs had full public efficacy trials in certain datasets as of 2023, driving firms to fund internal and external validation studies.

Encapsulation and spore technologies have enabled broader geographic reach — enabling product stability in regions with high thermal stress — and have shown to improve shelf-life by measurable multiples in lab studies (fact figures: probiotics 41.7%, dry format ~60–68%, <25% fully published trials). 

Five Recent Developments 

• Feb 2023 — Royal DSM launched a new eubiotics line targeting Salmonella control in swine, with field trials covering hundreds of commercial farms and measurable microbiome changes in trials (fact: multi-hundred farm trials reported). 
• 2023–2024 — Multiple major players (DSM, BASF, Cargill) increased feed-mill partnerships and captive premix agreements, leading to top supplier concentration estimates of ~40–45% in key markets (fact figure: 40–45% supplier concentration). 
• 2024 — New aquaculture-focused precision probiotic products were introduced (industry notices report multi-country launches and uptake in China, Vietnam, and Norway; fact: aquaculture share rose into double-digit percentages of livestock application). 
• 2024–2025 — BASF and peers reported enhanced gut-microbiome targeted formulations for swine and poultry with expanded registrations in 20–30 countries, accelerating geographic reach (fact: product registrations expanded across 20–30 countries). 
• 2025 — Industry reports show increased M&A and partnership activity, including acquisitions of niche eubiotic manufacturers by larger agribusinesses and increased R&D collaborations; market concentration and strategic vertical integration rose by reported mid-single digit percentage points. 

Report Coverage of Eubiotics Market

This report covers market sizing, segmentation by type (probiotics, organic acids, prebiotics, phytogenics and others), application (poultry, swine, ruminants, aquaculture, pets/others), form (solid/dry, liquid), function (gut-health, feed conversion, immunity) and regional analysis across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. It includes company profiling of leading suppliers, competitive share analysis (noting top-supplier concentration near 40–45% in some regions), product launch tracking (2023–2025), and channel analysis including feed-mill integration and premix distribution networks.

The methodology section documents primary interviews, survey samples covering hundreds of commercial farms and feed operators, and secondary sources; key quantitative anchors used include probiotics type share (~41.7%), poultry application share (~34.5%), Europe baseline (>43%), and regional form split (dry formats ~60–68%). The scope also examines regulatory environment, trial/validation coverage (noting under 25% fully published efficacy trials in select datasets).

Eubiotics Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5249.97 Million in 2026
Market Size Value By	USD 8427.96 Million by 2035
Growth Rate	CAGR of 5.4% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Probiotics Organic Acid By Application : Animals Application 2
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample